Allecra Therapeutics: Allecra Therapeutics' Licensing Agreement with Shanghai Haini Pharmaceutical
Baker McKenzie advised Allecra on the deal. Allecra Therapeutics completed a licensing agreement with Shanghai Haini Pharmaceutical Co., Ltd., part of the Yangtze River Pharmaceutical Group [...]
Read full article »
CEO
Allecra Therapeutics develops and commercializes novel antibiotics for the treatment of multi drug-resistant bacterial infections.
Read more